학술논문

Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.
Document Type
Correction Notice
Source
Trials. 11/14/2023, Vol. 24 Issue 1, p1-2. 2p.
Subject
*CHAGAS' disease
*CHRONIC diseases
*THERAPEUTICS
*RESEARCH protocols
*CLINICAL trials
Language
ISSN
1745-6215
Abstract
The document is a correction notice for an article titled "Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial." The correction states that the trial was originally conceived as a non-inferiority trial but was changed to a superiority trial due to feasibility issues. The authors calculated a new sample size based on published data and estimated that 237 patients would be needed. The original article has been corrected and the changes are attached to the correction notice. [Extracted from the article]